Research programme: antifolates - Center for Infectious Disease Research/ GlaxoSmithKline

Drug Profile

Research programme: antifolates - Center for Infectious Disease Research/ GlaxoSmithKline

Alternative Names: antituberculars- Center for Infectious Disease Research/ GlaxoSmithKline

Latest Information Update: 24 Oct 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Center for Infectious Disease Research; GlaxoSmithKline
  • Class Antibacterials; Antituberculars
  • Mechanism of Action Cell death modulators; Folate receptor 1 modulators; Folic acid transporter modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Research Mycobacterial infections

Most Recent Events

  • 13 Oct 2015 Early research in Mycobacterial infections in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top